Luxiq
NDC Package 0145-0021-50
Package Information
Luxiq is a medication used to treat skin conditions of the scalp (such as psoriasis, seborrhea). Marketed by Stiefel Laboratories Inc, this product is identified by NDC 0145-0021 and is authorized under FDA application NDA020934.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0145 - Stiefel Laboratories Inc
- 0145-0021 - Luxiq
- 0145-0021-50 - 1 CAN in 1 CARTON / 50 g in 1 CAN
- 0145-0021 - Luxiq
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0145-0021). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0145-0021-50 identifies a specific commercial package of 1 can in 1 carton / 50 g in 1 can of Luxiq, labeled by Stiefel Laboratories Inc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Stiefel Laboratories Inc on October 16, 2009. The current certification is valid through February 28, 2015.
What are the primary indications for this medication?
This medication is used to treat skin conditions of the scalp (such as psoriasis, seborrhea). Betamethasone works by decreasing the swelling (inflammation), itching, and redness. It belongs to a class of drugs known as corticosteroids. This medication is a medium-strength corticosteroid.
How is this Stiefel Laboratories Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00145002150. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 50 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.